Erythropoietin (EPO) in acute kidney injury

[1]  L. Celi,et al.  Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). , 2010, Kidney international.

[2]  T. Tulassay,et al.  Role of serum and glucocorticoid-regulated kinase-1 in the protective effects of erythropoietin during renal ischemia/reperfusion injury. , 2010, Biochemical pharmacology.

[3]  H. van Goor,et al.  Donor pretreatment with carbamylated erythropoietin in a brain death model reduces inflammation more effectively than erythropoietin while preserving renal function* , 2010, Critical care medicine.

[4]  O. Yokosuka,et al.  Low-Dose Darbepoetin α Attenuates Progression of a Mouse Model of Aristolochic Acid Nephropathy through Early Tubular Protection , 2009, Nephron Experimental Nephrology.

[5]  V. Bisesti,et al.  Downregulation of cell survival signalling pathways and increased cell damage in hydrogen peroxide‐treated human renal proximal tubular cells by alpha‐erythropoietin , 2009, Cell proliferation.

[6]  D. Chae,et al.  Prevention of Acute Kidney Injury by Erythropoietin in Patients Undergoing Coronary Artery Bypass Grafting: A Pilot Study , 2009, American Journal of Nephrology.

[7]  M. Zwahlen,et al.  Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials , 2009, The Lancet.

[8]  F. Grosjean,et al.  The improvement of ischemia/reperfusion injury by erythropoetin is not mediated through bone marrow cell recruitment in rats. , 2009, Transplantation proceedings.

[9]  R. Johnson,et al.  Nonrenal regulation of EPO synthesis. , 2009, Kidney international.

[10]  M. Benson,et al.  Erythropoietin-induced optimization of renal function after warm ischemia. , 2009, Journal of endourology.

[11]  D. Fliser,et al.  Erythropoietin and renoprotection , 2009, Current opinion in nephrology and hypertension.

[12]  I. Macdougall,et al.  Erythropoietins: a common mechanism of action. , 2008, Experimental hematology.

[13]  N. Karahan,et al.  The protective effect of erythropoietin on renal injury induced by abdominal aortic-ischemia-reperfusion in rats. , 2008, The Journal of surgical research.

[14]  L. Cantley,et al.  Erythropoietin expands a stromal cell population that can mediate renoprotection. , 2008, American journal of physiology. Renal physiology.

[15]  Allen R Nissenson,et al.  Epoetin‐associated pure red cell aplasia: past, present, and future considerations , 2008, Transfusion.

[16]  M. Percy,et al.  Familial erythrocytosis: molecular links to red blood cell control , 2008, Haematologica.

[17]  C. Diskin,et al.  Beyond Anemia: The Clinical Impact of the Physiologic Effects of Erythropoietin , 2008, Seminars in dialysis.

[18]  J. Jenkins,et al.  Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. , 2008, American journal of physiology. Renal physiology.

[19]  N. Ichimaru,et al.  Carbamylated Erythropoietin Improves Angiogenesis and Protects the Kidneys from Ischemia-Reperfusion Injury , 2008, Cell transplantation.

[20]  R. Bellomo,et al.  A multi-centre evaluation of the RIFLE criteria for early acute kidney injury in critically ill patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[21]  P. Chatterjee.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review , 2007, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  M. Santini,et al.  Structure, production and function of erythropoietin: implications for therapeutical use in cardiovascular disease. , 2007, Current medicinal chemistry.

[23]  R. Chang,et al.  Acute kidney injury in the intensive care unit according to RIFLE* , 2007, Critical care medicine.

[24]  R. Schrier,et al.  Erythropoietin ameliorates renal dysfunction during endotoxaemia. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  N. Ichimaru,et al.  Erythropoietin Protects the Kidneys Against Ischemia Reperfusion Injury by Activating Hypoxia Inducible Factor-1α , 2007, Transplantation.

[26]  K. Sugamura,et al.  Important Role of Erythropoietin Receptor to Promote VEGF Expression and Angiogenesis in Peripheral Ischemia in Mice , 2007, Circulation research.

[27]  W. Jelkmann.  Erythropoietin after a century of research: younger than ever , 2007, European journal of haematology.

[28]  S. Kong,et al.  Heat shock protein 70 inhibits the nuclear import of apoptosis‐inducing factor to avoid DNA fragmentation in TF‐1 cells during erythropoiesis , 2007, FEBS letters.

[29]  D. Nicol,et al.  Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigs , 2007, BJU international.

[30]  David W. Johnson,et al.  Novel renoprotective actions of erythropoietin: New uses for an old hormone (Review Article) , 2006, Nephrology.

[31]  Z. Endre,et al.  Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure. , 2006, Kidney international.

[32]  I. Tsouchnikas,et al.  Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  S. Rosen,et al.  A Role for Erythropoietin in the Attenuation of Radiocontrast-Induced Acute Renal Failure in Rats , 2006, Renal failure.

[34]  S. Yılmaz,et al.  Protective effect of erythropoietin on renal ischemia and reperfusion injury , 2005, ANZ journal of surgery.

[35]  M. Joyeux-faure,et al.  Erythropoietin and myocardial protection: what's new? , 2005, Fundamental & clinical pharmacology.

[36]  D. Kang,et al.  Renoprotective effect of erythropoietin (EPO): possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney. , 2005, Kidney international.

[37]  S. Elliott,et al.  Control of rHuEPO biological activity: the role of carbohydrate. , 2004, Experimental hematology.

[38]  K. Maiese,et al.  Erythropoietin on a Tightrope: Balancing Neuronal and Vascular Protection between Intrinsic and Extrinsic Pathways , 2004, Neurosignals.

[39]  N. Patel,et al.  Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. , 2004, Kidney international.

[40]  D. Allen,et al.  Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. , 2004, Journal of the American Society of Nephrology : JASN.

[41]  J. Frøkiaer,et al.  EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. , 2004, Kidney international.

[42]  N. Patel,et al.  ERYTHROPOIETIN ATTENUATES THE TISSUE INJURY ASSOCIATED WITH HEMORRHAGIC SHOCK AND MYOCARDIAL ISCHEMIA , 2004, Shock.

[43]  David W. Johnson,et al.  Erythropoietin protects against ischaemic acute renal injury. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[44]  L. Ragolia,et al.  Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells. , 2004, Kidney international.

[45]  Chul-woo Yang,et al.  Preconditioning with erythropoietin protects against subsequent ischemia‐reperfusion injury in rat kidney , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Yili Yang,et al.  Regulation of apoptosis: the ubiquitous way , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  Yan Tang,et al.  NF-kappaB plays a key role in hypoxia-inducible factor-1-regulated erythropoietin gene expression. , 2002, Experimental hematology.

[48]  S. Elliott,et al.  Comparison of the isoelectric focusing patterns of darbepoetin alfa, recombinant human erythropoietin, and endogenous erythropoietin from human urine. , 2002, Clinical chemistry.

[49]  C. Bagnis,et al.  Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[50]  Dick D. Mosser,et al.  Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome , 2000, Nature Cell Biology.

[51]  J. Myklebust,et al.  Protein kinase C-α isoform is involved in erythropoietin-induced erythroid differentiation of CD34+ progenitor cells from human bone marrow , 2000 .

[52]  F. Prósper,et al.  Erythropoietin Can Induce the Expression of Bcl-xLthrough Stat5 in Erythropoietin-dependent Progenitor Cell Lines* , 1999, The Journal of Biological Chemistry.

[53]  B. Beattie,et al.  Identification of the Erythropoietin Receptor Domain Required for Calcium Channel Activation* , 1999, The Journal of Biological Chemistry.

[54]  I. Wilson,et al.  Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide* , 1999, The Journal of Biological Chemistry.

[55]  C. Westenfelder,et al.  Human, rat, and mouse kidney cells express functional erythropoietin receptors. , 1999, Kidney international.

[56]  V. Katta,et al.  Microheterogeneity of erythropoietin carbohydrate structure. , 1995, Analytical chemistry.

[57]  S. Liao,et al.  Erythropoietin enhances recovery from cisplatin-induced acute renal failure. , 1994, The American journal of physiology.

[58]  Scott R. Presnell,et al.  Erythropoietin structure-function relationships. Mutant proteins that test a model of tertiary structure. , 1993, The Journal of biological chemistry.

[59]  M. Rohde,et al.  Peptide mapping and evaluation of glycopeptide microheterogeneity derived from endoproteinase digestion of erythropoietin by affinity high-performance capillary electrophoresis. , 1993, Analytical chemistry.

[60]  W. Keane,et al.  Recombinant erythropoietin rapidly treats anemia in ischemic acute renal failure. , 2001, Kidney international.

[61]  J. Myklebust,et al.  Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow. , 2000, Blood.

[62]  H. Bunn,et al.  Erythropoietin structure-function relationships. , 1990, Progress in clinical and biological research.